Clinical Trials
FEATURED REPORTS
WHAT'S NEW
-
PAT and TOC Analysis With an Onboard Automated Standards Introduction System ...
by Hach Ultra
White paper
<P>This paper describes the use of an on-board automated sample introduction system (OASIS) that is used to run verification standards and system suitability tests in order to ensure the reliability of the TOC results. </P>
-
Comparison of TOC Analyzers and Sensors for Pharmaceutical TOC Applications
by GE Analytical Instruments
Application note
In 2006, Jon S. Kauffman, PhD., Lancaster Laboratories, published results from a study on the recovery of organic compounds likely to be present in pharmaceutical water systems using on-line TOC analyzers designed for pharmaceutical use. A new study repeats the same injections, but adds the new CheckPoint TOC Sensor from GE Analytical Instruments.
REPORTS BY SUBTOPIC
Integrating good manufacturing practices during the transition from clinical ...
By Ross Systems Inc.
White paper
According to this white paper by Ross Systems Inc., early adoption of good manufacturing practice (GMP) can lead to a faster, lower-cost ramp-up from clinical trials to full commercial manufacturing, whether in house or outsourced.
Instantaneous Microbial Detection
By BioVigilant Systems Inc.
White paper
This white paper by BioVigilant Systems Inc. discusses its optical technology, which can determine the quantity and size of particles in liquid or air and whether each particle is inert or biologic, resulting in instantaneous and continuous microbial detection.
Symposium on risk in supply chains
By Product Surety Center
White paper
This white paper is based on a variety of discussions from a 2005 symposium of the Product Surety Center (PSC), a resource center for industries and government agencies involved in ensuring the security and safety of products. The addressed what it characterized as an overlooked player in U.S. safety and security -- the private sector and its global supply chains.
Improving employee performance and compliance in the life science industries
By Blue Mountain Quality Resources Inc.
White paper
This white paper by Blue Mountain Quality Resources Inc. discusses the importance of employee performance and training, including in areas such as regulatory asset management.
Leveraging IT to transform drug discovery
By Infosys Technologies Ltd.
White paper
This white paper by Infosys Technologies Ltd. describes how a hypothetical plasma therapeutics company leveraged information technology to reduce drug development costs.
Customer and Quintiles team up for greater speed
By Quintiles Transnational Corp.
White paper
In this case study, Quintiles Transnational meets the requests of a top 10 pharmaceutical company looking to reduce the time to database lock by two months.
Regulatory compliance in life sciences: Leveraging integration competency ...
By Informatica Corp.
White paper
This white paper by Informatica Corp. examines some of the issues regarding implementing information risk management technologies to increase compliance in the life sciences sector.
The essentials of stability test services
By MDS Pharma Services
White paper
This white paper by MDS Pharma Services describes the testing that a drug must undergo before it is launched in the market.
Drug Formulation Options - Oral technologies
By Cardinal Health
Product collateral
Cardinal Health provides many formulation options to give pharmaceutical companies a competitive edge. Cardinal Health has developed and manufactured advanced drug delivery stystems for more than 50 years and continue to help enhance the therapeutic and market performance of their customers' drugs. <BR>
Topical Technologies
By Cardinal Health
Product collateral
Cardinal Health offers a large portfolio of topical technologies including Microsponge and DelPouch. Scientists offer information, consultation and partnership to developers, manufacturers and marketers interested in pursuing different topical applications for molecules, compounds and products.
Phase I-IIA Clinical Pharmacology Services
By AAI Pharma Inc.
Product collateral
AAIPharma's Phase I-IIA Clinical Pharmacology services offer experienced research teams of physicians, nurses, technicians and CRAs, rapid subject recruitment, healthy volunteers as well as special populations, a focus on volunteer and patient safety, regulatory compliance, and strict adherence to the protocol.
What's in a name? Using definitive DNA typing
By DuPont Qualicon
Case study
In this case study, DuPont Qualicon uses its RiboPrinter microbial characterization to definitively identify a wide range of bacteria.
Strategies to identify and confirm metabolites using the 4000 Q TRAP System
By Applied Biosystems
Application note
In this application note, Applied Biosystems describes the superior sensitivity of 4000 Q TRAP System that provides ultra low-level detection of metabolites, which combined with the variety of scan modes facilitates metabolite identification capabilities which is best suited for Phase I and II metabolite screening where the lists of expected metabolites are easily compiled.
Designing a comprehensive cardiovascular safety testing regimen
By Covance Inc.
White paper
In this white paper, Covance Inc. discusses the need for a careful analysis of any medicine's impact on cardiac safety, to avoid unanticipated and hazardous effects on the heart.
Suppressive effects of topical nanocrystalline silver in allergic contact ...
By Nucryst Pharmaceuticals Corp.
White paper
This white paper by Nucryst Pharmaceuticals suggests that nanocrystalline silver cream showed significant inhibitory activity against contact dermatitis in mice, similar to high potency steroid and tacrolimus.
Phase I-IIA Clinical Pharmacology Services
By AAI Pharma Inc.
Product collateral
AAIPharma's Phase I-IIA Clinical Pharmacology services offer experienced research teams of physicians, nurses, technicians and CRAs, rapid subject recruitment, healthy volunteers as well as special populations, a focus on volunteer and patient safety, regulatory compliance, and strict adherence to the protocol.
Strategies to identify and confirm metabolites using the 4000 Q TRAP System
By Applied Biosystems
Application note
In this application note, Applied Biosystems describes the superior sensitivity of 4000 Q TRAP System that provides ultra low-level detection of metabolites, which combined with the variety of scan modes facilitates metabolite identification capabilities which is best suited for Phase I and II metabolite screening where the lists of expected metabolites are easily compiled.
Phase II-IV Clinical Trials Services
By AAI Pharma Inc.
Product collateral
AAIPharma's Phase II-IV Clinical Trials services offers highly qualified clinical research teams including project managers, physicians and scientists, clinical research associates (CRAs), biostatisticians, data managers, medical writers, quality and regulatory specialists, working relationships with a network of study sites around the world, and eClinical technologies to assure critical path...
Phase II-IV Clinical Trials Services
By AAI Pharma Inc.
Product collateral
AAIPharma's Phase II-IV Clinical Trials services offers highly qualified clinical research teams including project managers, physicians and scientists, clinical research associates (CRAs), biostatisticians, data managers, medical writers, quality and regulatory specialists, working relationships with a network of study sites around the world, and eClinical technologies to assure critical path...
